Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.

To understand the role of intercellular adhesion molecule-1 (ICAM-1) in tumor progression in the host, we examined ICAM-1 expression in breast cancer by immunohistochemistry. This study included 274 female patients with invasive breast cancer, with a median follow-up of 98 months. The molecule was identified in formalin-fixed, paraffin-embedded primary tumors, and the relationship to clinicopathological factors and prognosis was analyzed. ICAM-1 expression occurred in 50.3% of patients. ICAM-1 expression had negative correlation to tumor size (P = 0.003), lymph node metastasis (P < 0.0001), tumor infiltration (P = 0.003), nuclear pleomorphism (P = 0.004), and nuclear grade (P = 0.042). Patients with ICAM-1-positive tumors had better relapse-free and overall survival than those with negative tumors (P < 0.0001 and P = 0.0003, respectively). These results suggest that expression of ICAM-1 on cancer cells might have a role as a suppressor of tumor progression under the host immune surveillance system.

[1]  S. Thibodeau,et al.  Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. , 1996, Cancer research.

[2]  S. Amano,et al.  Local expression and circulating form of ICAM-1 in colorectal cancer , 1996 .

[3]  C. M. Steel,et al.  Regulation of ICAM‐1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast‐derived factors , 1994, International journal of cancer.

[4]  W. Dippold,et al.  Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. , 1993, Gut.

[5]  W. Dippold,et al.  De Novo expression of intercellular adhesion molecule 1(ICAM‐1, CD54) in pancreas cancer , 1993, International journal of cancer.

[6]  R. Rothlein,et al.  A form of circulating ICAM-1 in human serum. , 1991, Journal of immunology.

[7]  S. Meuer,et al.  Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway. , 1991, International immunology.

[8]  J. Revillard,et al.  Expression, function and regulation of the intercellular adhesion molecule‐1 (ICAM‐1) on human intestinal epithelial cell lines , 1991, European journal of immunology.

[9]  Y. Hinoda,et al.  Detection of circulating intercellular adhesion molecule‐1 antigen in malignant diseases , 1991, Clinical and experimental immunology.

[10]  M. Raimondo,et al.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. , 1991, Gastroenterology.

[11]  Y. Tomita,et al.  Expression of intercellular adhesion molecule‐1 (ICAM‐1) on renal‐cell cancer: Possible significance in host immune responses , 1990, International journal of cancer.

[12]  S. Ferrone,et al.  Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. , 1990, Cancer research.

[13]  R. Klausner,et al.  Class II MHC molecules can use the endogenous pathway of antigen presentation , 1990, Nature.

[14]  G. Rice,et al.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. , 1989, Science.

[15]  M. Patarroyo,et al.  Leucocyte Adhesion to Cells , 1989, Scandinavian journal of immunology.

[16]  R. Greil,et al.  Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. , 1989, Clinical and experimental immunology.

[17]  J. Voorhees,et al.  Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. , 1989, Journal of the American Academy of Dermatology.

[18]  J. Johnson,et al.  De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Parham,et al.  Cell-cell adhesion mediated by CD8 and MHC class I molecules , 1988, Nature.

[20]  T. Springer,et al.  ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.

[21]  Timothy A. Springer,et al.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) , 1987, Cell.

[22]  F. Momburg,et al.  The influence of major histocompatibility complex class I antigens on tumor growth and metastasis. , 1987, Biochimica et biophysica acta.

[23]  J. Strominger,et al.  Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.

[24]  Michael Loran Dustin,et al.  The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. , 1987, Annual review of immunology.

[25]  M. Rijn,et al.  Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. , 1986, Science.

[26]  H. Pircher,et al.  A monoclonal antibody against altered LFA‐1 induces proliferation and lymphokine release of cloned T cells , 1986, European journal of immunology.

[27]  L. Sobin,et al.  Histological Typing of Breast Tumors 1 , 1982 .

[28]  R. W. Scarff,et al.  Histological typing of breast tumors. , 1982, Tumori.

[29]  F. Mostofi,et al.  THE SIGNIFICANCE OF CYTOPLASMIC GRANULARITY IN THE PROGNOSIS OF RENAL CELL CARCINOMA. , 1965, The Journal of urology.

[30]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.